In a remarkable pivot, Athira Pharma has a deal to test a promising breast cancer drug and landed $90 million in upfront funding from investors. Read More
New funding: Concure Oncology is raising investment for its Breast Microseed treatment, which helps to prevent breast cancer from recurring.… Read More